Hyderabad-based Orbicular Pharmaceutical Technologies announced that its generic version of Ozempic (semaglutide injection), developed with Apotex, has received tentative approval from the USFDA. The ...
The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company ...
Global pharma major Lupin Limited on Tuesday announced that it has received approval from the United States Food and Drug ...
US FDA approves Apotex’s generic Infuvite paediatric injection, eligible for 180 day CGT exclusivity: Weston, Florida Wednesday, April 29, 2026, 15:00 Hrs [IST] Apotex, in colla ...
The MarketWatch News Department was not involved in the creation of this content. Partner Apotex Corp. (Apotex) to market and distribute to the U.S. healthcare market MIRAMAR, Fla., April 9, 2026 ...
Mumbai/Naples: Lupin Limited has strengthened its U.S. generics portfolio with the latest approval from the United States ...
Caplin Steriles Limited (CSL), a subsidiary of Caplin Point Laboratories Limited, has received final approval from the United ...
MIRAMAR, Fla., March 11, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has ...
Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook ...
Cipla Share Price Target 2026: Founded in 1935, Cipla has a major presence across India, South Africa, and North America. The company has 46 advanced manufacturing hubs, producing over 1,500 products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results